OXFORD EXPRESSION TECHNOLOGIES LIMITED
Significant control: Prof Linda Anne King (significant control), Professor Robert David Possee (significant control) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Oxford Expression Technologies Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Oxford Expression Technologies Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
OXFORD EXPRESSION TECHNOLOGIES LIMITED is an active private limited company (company number 05874405) incorporated on 12 July 2006, registered in Newbury. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 October 2025, showing net assets of £2.76m and cash of £1.70m, with 15 employees on average. Net assets rose 6% on the prior period (£2.61m).
By net assets it sits in the top quarter of 50 comparable companies in Reading (median £11k, upper quartile £207k).
Ownership and control
- Prof Linda Anne King
- has significant influence or control
- Professor Robert David Possee
- has significant influence or control
- Mr Brendan Casey
- holds 25–50% of voting rights
- Professor Alistair David Fitt
- holds 25–50% of voting rights
- Mr Edward Bernard
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 July 200620 yrs ago
- Next accounts due
- 31 July 2027in 279 days
- Confirmation statement due
- 26 July 2027in 274 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £2.76m | £1.70m | — | £187k | — | £477k | 15 |
| 31 October 2024 | £2.61m | £2.01m | — | £317k | — | £718k | 18 |
| 1 November 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £2,764,907 at 31 October 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 11.83
- Cash at bank of £50,000 or moreCash £1,701,088
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 12 July 2006
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 279 days
- Confirmation statement duein 274 days
- Accounts period endNet assets £2.76m · small accounts
- Accounts period endNet assets £2.61m · small accounts
- Accounts period end
- Incorporated
Similar companies in Reading
- OET LIMITEDNewbury · inc. Jul 2006
- BROADMIND SCIENCE LIMITEDHook · inc. Dec 2005
- SIGNANT HEALTH INC. LIMITEDReading · inc. May 2004
- IQVIA LABORATORIES DISCOVERY UK LTDReading · inc. Dec 2002
- TWISTDX LIMITEDMaidenhead · inc. Sept 2002
- OLD CONVERGENCE PHARMACEUTICALS LIMITEDMaidenhead · inc. Jun 2010
All companies incorporated on 12 July 2006 · in Jul 2006.
Reminders for OXFORD EXPRESSION TECHNOLOGIES LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.